PATENT CLAIM ANALYSIS

Application Number: 15867829
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "003800"]

Abstract:
The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.

Claim (Index 11):
The method according to  claim 7 , said method comprising measuring the size of the replication competent HIV reservoir in said subject prior to the administration of said first dose of GH to said subject, at the conclusion of said first period of time and at the conclusion of said second time period where said second dose of GH is administered.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15114296', '13794467', '15429311', '11877395', '10969463']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7383863570384562
- 35 USC 102 Novelty (BERT): 0.4993041524386252
- Combined Prediction Score: 0.7144781365784731
- Mean Citation Score: 195.07115
- Max Citation Score: 212.00377000000003
- Similarity Product: 136.38974541994216

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test